April 06, 2015
Novartis Pharmaceuticals Corp. will pay $12.25 million and royalties to Juno Therapeutics Inc. to settle a three-year-old patent dispute over cancer immunotherapy drugs between a university and a hospital with which they struck licensing deals, the parties said on Monday.
March 25, 2013
The University of Pennsylvania on Friday sought to declare invalid a patent held by St. Jude Children's Hospital related to a "groundbreaking" new immunotherapy treatment for cancer that is at the center of a pitched legal battle between the former collaborators.